维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Wandt H"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Safety and cost effectiveness of a 10 X109/L trigger for prophylactic platelet transfusions compared with the traditional 20 X109/L trigger: a prospective comparative trial_ in 105 patients with acute myeloid leukemia显示文摘	Wandt H Frank M Ehninger G	1998	Blood1998，91，：	1
2	MLD according to the WHOclassification in AML has no correlation with age and no independ-ent prognostic relevance as analyzed in 1766 patients显示文摘	Wandt H Schakel U Kroschinsky	2008	Blood2008，111，：	1
3	Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, muhicentre, randomised study显示文摘	Wandt H Wendelin K	2012	The Lancet2012，，：	1
4	Safty and cost effectiveness of a 10 X 109/L trigger forprophylactic platelet transfusions compared with the traditional20 X 109 /L trigger: a prospective comparative trial in 105 pa-tients with acute myeloid leukemia 显示文摘	Wandt H Frank M Ehninger G* Schneider C Brack N DaoudA	1998	Blood1998，91，：	1
5	New Strategies for prophylactic platelet transfusion in patients with hematologic diseases 显示文摘	Wandt H Ehninger G Gallmeier WM	2001	Oncologist2001，6，5：	1
6	Safety and cost effectiveness of a 1010/trigger for prophylactic platelet transfusions compared with the traditional 2010/trigger:a rpspective comarative thal in 105 patients with acute myeloid leukemia显示文摘	Wandt H Frank M Ehninger G	1998	Blcod1998，9，：	1
7	Immuno- phenotyping is an independent factor for risk stratification in AML 显示文摘	Repp R Schaekel U Helm G Thiede C Soucek S Pascheberg U Wandt H Aulitzky W Bodenstein H Sonnen R Link H Ehninger G Gramatzki M AML- SHG Study Group	2003	Cytometry B Clin Cytom2003，53，1：	1
8	Safety and cost effectiveness of a 10 X 10^9/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10^9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia 显示文摘	Wandt H Frank M Ehninger G	1998	Blood1998，91，10：	1
9	Safety and cost effectiveness of a 10×109/L trigger for prophylactic platelet transfusions compared with the traditional 20×109/L trigger:a prospective comparative trial in 105 patients with acute myeloid leukemia显示文摘	Wandt H Frank M Ehninger G	1998	Blood1998，91，10：	1
10	Phase Ⅲ trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer,intergroup trial of the AGO-Ovar/AIO and EBMT显示文摘	Wandt H Frickhofen N	2007	J Clin Oncol2007，25，27：	1
11	New strategy for platelet transfusion in patients with acute myeloid leukemia:Routine prophylactic transfusion replaced by therapeutic transfusion显示文摘	Wandt H Reinel H Schaefer-Eckart K	2002	Blood2002，100，11：	1
12	Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells:a phase I/II study in advanced ovarian cancer显示文摘	Wandt H Birkman J Denzel T	1999	Bone Marrow Transplant1999，23，：	1
13	A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation显示文摘	Wandt H Schaefer E K Frank M	2006	Bone Marrow Transplantation2006，37，4：	1
14	Safety of the 10×103/μLtrigger for prophylactic platelet transfusion:prospective multicenter experience in 734 patients with acute myeloid leukemia显示文摘	Wandt H Frank M Granmatzki M	2000	Blood2000，96，1：	1
15	Supraglottic laryngectomy for intermediate stage cancer: UT MD anderson cancer center experience with combined therapy 显示文摘	Lee NK Ooepfert H Wandt CD	1990	Laryngoscope1990，100，：	1
16	Safety of the 10×103/μLtrigger for prophylactic platelet transfusion:prospective multicenter experience in 734 patients with acute myeloid leukemia显示文摘	FRANK M GRANMATZKI M	2000	Blood2000，96，1：	1
17	Bane marrow transplantation unit, medical departments显示文摘	Wandt H	1997	Oncology Klinkin Nurabery Germany1997，5，：	1
18	Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label,multicentre,randomised- study显示文摘	Wandt H Schaefer-Eckart K Wendelin K	2012	Lancet2012，380，9850：	1
19	Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors:the EBMT experience显示文摘	De Giorgi U Demirer T Wandt H	2005	Ann Oncol2005，16，1：	1
20	Safety and cost effectiveniss of a 10 ×10^9/L threshold for prophylactic platelet transfusions compared with the traditional 20×10^9/L threshold:a prospective comparative trial in 105 patients with acute myeloid leukemia显示文摘	Wandt H Frank M Ehninger G	1998	Blood1998，91，10：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示